Khokhriakov A L, Mingazova E N
Biomedical University of Innovation and Continuing Education of the State Scientific Center of the Russian Federation - A. I. Burnazyan Federal Medical Biophysical Center of the Federal Medical Biological Agency of Russia, 123098, Moscow, Russia.
Russian Medical Scientific and Production Center "Rosplasma" of the Federal Medical Biological Agency of Russia, 610002, Kirov, Russia.
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2024 Jun;32(Special Issue 1):676-680. doi: 10.32687/0869-866X-2024-32-s1-676-680.
As an analysis of foreign literature on donation has shown, the global market for therapy with drugs from human plasma is growing, which leads to the need for large volumes. With significant geographic imbalances in the global plasma supply and the dependence of most countries on plasma supplies from the United States, the most vulnerable are low- and middle-income countries, where the challenge of meeting the demand for plasma products requires improvements to regional plasma donation systems. An effective tool for the development of plasma collection services is compliance with the standards of plasma donation services, the development of voluntary free plasma donation, and the optimization of donor recruitment and retention processes.
正如对国外捐赠文献的分析所示，全球人血浆药物治疗市场正在增长，这导致对大量血浆的需求。由于全球血浆供应存在严重的地理不平衡，且大多数国家依赖美国的血浆供应，最脆弱的是低收入和中等收入国家，在这些国家，满足血浆产品需求的挑战需要改进区域血浆捐赠系统。血浆采集服务发展的有效工具是遵守血浆捐赠服务标准、发展自愿无偿献血以及优化献血者招募和保留流程。
